22 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
notice or other communication from the FDA, USDA, FSIS, AMS, FTC, the Department of Justice, any state attorney general or any private enforcer acting … as a private attorney general or other Regulatory Authority or Governmental Entity, including any Warning Letter, Untitled Letter, notice of violation
424B3
2pcnduaaq tmw
4 Nov 13
Prospectus supplement
12:00am
POS AM
e6xc3ohq6f6ht b5
9 Oct 13
Prospectus update (post-effective amendment)
12:00am
424B5
pdfy493x6z2z52k2x1rg
15 Mar 13
Prospectus supplement for primary offering
12:00am
424B3
t99j mm0j
12 Mar 13
Prospectus supplement
12:00am
424B5
81oi99cpj4gplqm 77
7 Mar 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
qiywwp a0c
25 Jan 13
Special Note Regarding Forward-Looking Statements
12:00am
424B3
w86iqc4
12 Dec 12
Prospectus supplement
12:00am
S-1
jh4qz0bt249 avmdte4y
27 Nov 12
IPO registration
12:00am